静止剂在坟墓中 轨道病变:一种新的治疗工具
Giulia Lanzolla1,2, Simone Comi1, Giada Cosentino1
1Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Pisa, Italy.
Ophthalmic plastic and reconstructive surgery
|December 6, 2023
概括
类药物可以通过降低胆固醇和提供其他好处来预防和治疗Graves轨道病变 (GO). 这篇评论探讨了胆固醇的研究.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 眼科医生 眼科 眼科
背景情况:
- 格雷夫斯轨道病 (GO) 是一种与格雷夫斯病相关的自身免疫性疾病.
- 目前的治疗方法,如静脉注射葡萄皮质激素 (IVGCs) 是有效的,但可以加强.
- 胆固醇在GO病原和治疗反应中的作用是一个新兴的兴趣领域.
研究的目的:
- 审查当前关于胆固醇和降胆固醇药物的证据在Graves轨道病.
- 探索GO患者潜在的新疗法策略.
主要方法:
- 在PubMed.com上进行了全面的文献搜索.
- 包括从1980年到2023年发表的研究.
- 搜索术语包括"格雷夫斯轨道病","胆固醇","他类药物"和"atorvastatin".
主要成果:
- 低密度脂蛋白胆固醇与GO风险和疾病过程相关.
- 降胆固醇药物,特别是他类药物,在GO预防方面显示出潜在的益处.
- 最近的一项试验表明,阿托瓦斯塔丁与IVGCs结合,改善了高胆固醇血清GO患者的治疗结果.
结论:
- 类他类药物似乎在中度至重度活跃的GO中具有预防性和治疗性作用.
- 它们的有效性可能源于降低胆固醇,增肥效应和药物相互作用.
- 管理高胆固醇血症可能是一个有价值的辅助治疗GO.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
671
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
671
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.0K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.0K
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


